Fennec Pharmaceuticals Announces $12.5 Million Debt Financing With Bridge Bank Read more about Fennec Pharmaceuticals Announces $12.5 Million Debt Financing With Bridge Bank
Fennec Pharmaceuticals Initiates Rolling New Drug Application to U.s. Food and Drug Administration for PEDMARK™ Read more about Fennec Pharmaceuticals Initiates Rolling New Drug Application to U.s. Food and Drug Administration for PEDMARK™
Fennec Pharmaceuticals Announces Scientific Symposium on Ototoxicity in Pediatric Cancer Patients at the 50th Congress of the International Society of Pediatric Oncology (SIOP) 2018 Meeting Read more about Fennec Pharmaceuticals Announces Scientific Symposium on Ototoxicity in Pediatric Cancer Patients at the 50th Congress of the International Society of Pediatric Oncology (SIOP) 2018 Meeting
Fennec Provides Business Update and Announces Third Quarter 2018 Financial Results Read more about Fennec Provides Business Update and Announces Third Quarter 2018 Financial Results
Fennec to Present at Cantor Fitzgerald Global Healthcare Conference on October 1, 2018 in New York City Read more about Fennec to Present at Cantor Fitzgerald Global Healthcare Conference on October 1, 2018 in New York City
Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results Read more about Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results
Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan From European Medicines Agency for PEDMARK(TM) and Confirmation of Eligibility for a Pediatric Use Marketing Authorization Read more about Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan From European Medicines Agency for PEDMARK(TM) and Confirmation of Eligibility for a Pediatric Use Marketing Authorization
Fennec Announces Publication of Pedmark(TM) Siopel 6 Clinical Data in the New England Journal of Medicine Read more about Fennec Announces Publication of Pedmark(TM) Siopel 6 Clinical Data in the New England Journal of Medicine
Fennec Pharmaceuticals Set to Join Russell 3000 Index Read more about Fennec Pharmaceuticals Set to Join Russell 3000 Index
Fennec Announces Results of Annual Meeting Read more about Fennec Announces Results of Annual Meeting
